Fractyl Health Unveils New Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025

[
Fractyl Health Unveils New Rejuva ® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025
[og_img]
https://www.investing.com/news/press-releases/fractyl-health-unveils-new-rejuva–smart-glp1-pancreatic-gene-therapy-preclinical-data-highlighting-durable-potency-and-safety-with-limited-systemic-glp1-exposure-at-asgct-2025-93CH-4051545


Investing.com